Publications by authors named "Laura Turunen"

Claim this Profile
E
Evaluation of BH3 mimetics as a combination therapy with irradiation in head and neck squamous cell carcinoma.
Katja Korelin, Mayke Oostveen, Wafa Wahbi, Filipp Ianevski, Bruno Cavalcante, Laura Turunen

Biomed Pharmacother· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.
Mariia S Bogacheva, Suvi Kuivanen, Swapnil Potdar, Antti Hassinen, Sini Huuskonen, Laura Turunen

Antiviral Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2.
Vilja Pietiäinen, Minttu Polso, Ede Migh, Christian Guckelsberger, Maria Harmati, Laura Turunen

Cell Rep Methods· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT).
Michaela Feodoroff, Piia Mikkonen, Laura Turunen, Antti Hassinen, Lauri Paasonen

SLAS Discov· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well plates.
Michaela Feodoroff, Piia Mikkonen, Mariliina Arjama, Astrid Murumägi, Olli Kallioniemi, Laura Turunen

SLAS Discov· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.
Heike Peterziel, Nora Jamaladdin, Dina ElHarouni, Xenia F Gerloff, Sonja Herter, Laura Turunen

NPJ Precis Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia.
Disha Malani, Ashwini Kumar, Oscar Brück, Mika Kontro, Bhagwan Yadav, Laura Turunen

Cancer Discov· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iTReX: Interactive exploration of mono- and combination therapy dose response profiling data.
Dina ElHarouni, Yannick Berker, Heike Peterziel, Apurva Gopisetty, Laura Turunen

Pharmacol Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma.
Katja Tuomainen, Aini Hyytiäinen, Ahmed Al-Samadi, Philipp Ianevski, Aleksandr Ianevski, Laura Turunen

Sci Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations.
Aleksandr Ianevski, Jenni Lahtela, Komal K Javarappa, Philipp Sergeev, Bishwa R Ghimire, Laura Turunen

Sci Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer.
Chiara Facciotto, Julia Casado, Laura Turunen, Suvi-Katri Leivonen, Manuela Tumiati

Clin Epigenetics· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Tumor-Derived Matrix Improves the Predictability of Head and Neck Cancer Drug Testing.
Katja Tuomainen, Ahmed Al-Samadi, Swapnil Potdar, Laura Turunen, Minna Turunen

Cancers (Basel)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods for High-throughput Drug Combination Screening and Synergy Scoring.
Liye He, Evgeny Kulesskiy, Jani Saarela, Laura Turunen, Krister Wennerberg

Methods Mol Biol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins.
Daria Bulanova, Aleksandr Ianevski, Andrii Bugai, Yevhen Akimov, Suvi Kuivanen, Laura Turunen

Viruses· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Cancer Medicine in the Acoustic Dispensing Era: Ex Vivo Primary Cell Drug Sensitivity Testing.
Evgeny Kulesskiy, Jani Saarela, Laura Turunen, Krister Wennerberg

J Lab Autom· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MINC1, a GTPase-activating protein small molecule inhibitor, targeting MgcRacGAP.
Arjan J van Adrichem, Annika Fagerholm, Laura Turunen, Anna Lehto, Jani Saarela

Comb Chem High Throughput Screen· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Mapping of Kinase Addiction Combinations in Breast Cancer Cells by Integrating Drug Sensitivity and Selectivity Profiles.
Agnieszka Szwajda, Prson Gautam, Leena Karhinen, Sawan Kumar Jha, Jani Saarela, Laura Turunen

Chem Biol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The high throughput biomedicine unit at the institute for molecular medicine Finland: high throughput screening meets precision medicine.
Vilja Pietiainen, Jani Saarela, Carina von Schantz, Laura Turunen, Paivi Ostling

Comb Chem High Throughput Screen· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of in situ ELISA method for examining Trk receptor phosphorylation in cultured cells.
Hanna Antila, Henri Autio, Laura Turunen, Kirsi Harju, Päivi Tammela

J Neurosci Methods· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.
Tea Pemovska, Mika Kontro, Bhagwan Yadav, Henrik Edgren, Samuli Eldfors, Laura Turunen

Cancer Discov· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A structural insight into the molecular recognition of a (-)-Delta9-tetrahydrocannabinol and the development of a sensitive, one-step, homogeneous immunocomplex-based assay for its detection.
Merja H Niemi, Laura Turunen, Timo Pulli, Tarja K Nevanen, Matti Höyhtyä

J Mol Biol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated panning and screening procedure on microplates for antibody generation from phage display libraries.
Laura Turunen, Kristiina Takkinen, Hans Söderlund, Timo Pulli

J Biomol Screen· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis